Cent Eur J Public Health 2025, 33(3):155-162 | DOI: 10.21101/cejph.a8486

Inequalities in cervical cancer screening use: results of the Serbian National Health Survey

Dragana Milijašević1, 2, Tatjana Tamaš1, 3, Sonja Čanković1, 2, Snežana Ukropina1, 2, Sonja Šušnjević4, Tanja Tomašević1, 2, Dušan Čanković1, 2, Vesna Mijatović Jovanović1, 2
1 Faculty of Medicine, University of Novi Sad, Autonomous Province of Vojvodina, Novi Sad, Serbia
2 Institute of Public Health of Vojvodina, Autonomous Province of Vojvodina, Novi Sad, Serbia
3 Oncology Institute of Vojvodina, Autonomous Province of Vojvodina, Novi Sad, Serbia
4 Health Care District of Palm Beach County, West Palm Beach, Florida, United States of America

Objectives: Cervical cancer represents a significant public health concern worldwide, particularly among women of reproductive age. According to data from the Cancer Registry of the Republic of Serbia for the year 2022, cervical cancer is the fourth most common cancer in women, with an age-standardized incidence rate (ASIR) of 24.8/100,000 and the fourth leading cause of mortality, with an age-standardized mortality rate (ASMR) of 10.2/100,000. This study aimed to analyse the association between socio-demographic factors, unmet healthcare needs, and cervical cancer screening use among women in Serbia.

Methods: Research was conducted as a cross-sectional study on a sample of 3,980 women aged 25-64 in Serbia. Three types of questionnaires were used as a research instrument. The association of missed cervical smear tests in the last 3 years with independent variables was examined by univariate and binary logistic regression model.

Results: According to socio-demographic characteristics, the likelihood of missing a cervical smear test in the last 3 years increased with age, being highest among older women (OR = 1.91, 95% CI: 1.88-1.94), lower-income categories (OR = 1.76, 95% CI: 1.74-1.78), and women with the lowest levels of education (OR = 1.49, 95% CI: 1.47-1.52). The logistic regression model revealed significant territorial disparities, with the highest predicted probability for women from South and East Serbia (OR = 1.73, 95% CI: 1.70-1.76). Additionally, distance/transportation and financial constraints were significantly associated with missed cervical smear tests in the last 3 years (OR = 2.05, 95% CI: 1.99-2.11; OR = 1.10, 95% CI: 1.08-1.12, respectively).

Conclusions: Socioeconomic disparities in cervical cancer screening remain a challenge. This study highlights the need to allocate resources to areas in need of improvement and also to conduct comprehensive evaluations of screening systems, which can lead to significant reductions in cervical cancer incidence and mortality.

Klíčová slova: women, healthcare inequalities, Pap test, cancer screening, assessment of healthcare needs

Vloženo: 10. prosinec 2024; Revidováno: 5. září 2025; Přijato: 5. září 2025; Zveřejněno: 30. září 2025  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Milijašević D, Tamaš T, Čanković S, Ukropina S, Šušnjević S, Tomašević T, et al.. Inequalities in cervical cancer screening use: results of the Serbian National Health Survey. Cent Eur J Public Health. 2025;33(3):155-162. doi: 10.21101/cejph.a8486.
Stáhnout citaci

Reference

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209-49. Přejít k původnímu zdroji...
  2. World Health Organization, International Agency for Researcs on Cancer. Cancer today. Age-standardized rate (world) per 100 000, incidence and mortality, females, age [25-64], in 2022: cervix uteri [Internet]. IARC; 2024 [cited 2025 Sep 1]. Available from: https://gco.iarc.fr/today/en/dataviz/bars?types=0_1&mode=population&sort_by=value1&populations= 100_112_191_196_203_208_233_246_250_276_300_348_352_372_380_40_428_440_442_470_498_499_528_56_578_616_620_642_643_688_70_703_705_724_752_756_8_804_807_826&cancers=23&sexes=2&age_start=5&age_end=12.
  3. Institute of Public Health of Serbia "Dr. Milan Jovanović Batut". Malignant tumours in Republic of Serbia 2021 [Internet]. Belgrade; 2023 [cited 2025 Sept 1st]. Available from: https://www.batut.org.rs/download/publikacije/MaligniTumoriURepubliciSrbiji2021.pdf.
  4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. Přejít k původnímu zdroji...
  5. U.S. Centers for Disease Control and Prevention. Cervical cancer. Screening for cervical cancer [Internet]. Atlanta: CDC; 2025 [cited 2024 Jul 23]. Available from: https://www.cdc.gov/cervical-cancer/screening/index.html.
  6. [Decree of the Government of Republic of Serbia on the National Cervical Cancer Early Detection Program]. Službeni glasnik Republike Srbije. 2013 Aug 16;69(Pt 73):9-15. Serbian.
  7. Djordjevic S, Boricic K, Radovanovic S, Simic Vukomanovic I, Mihaljevic O, Jovanovic V. Demographic and socioeconomic factors associated with cervical cancer screening among women in Serbia. Front Public Health. 2024 Jan 5;11:1275354. doi: 10.3389/fpubh.2023.1275354. Přejít k původnímu zdroji... Přejít na PubMed...
  8. Başar D, Dikmen FH, Öztürk S. The prevalence and determinants of unmet health care needs in Turkey. Health Policy. 2021 Jun;125(6):786-92. Přejít k původnímu zdroji...
  9. Popovic N, Terzic-Supic Z, Simic S, Mladenovic B. Predictors of unmet health care needs in Serbia; Analysis based on EU-SILC data. PLoS One. 2017 Nov 8;12(11):e0187866. doi: 10.1371/journal.pone.0187866. Přejít k původnímu zdroji... Přejít na PubMed...
  10. [Act on health care]. Službeni glasnik Republike Srbije. 2019 Apr 3;75(Pt 25):40-87. Serbian.
  11. Bjegovic-Mikanovic V, Vasic M, Vukovic D, Jankovic J, Jovic-Vranes A, Santric-Milicevic M, et al. Serbia: health system review. Health Syst Transit. 2019 Oct;21(3):1-211.
  12. European Health Interview Survey (ЕHIS wave 3). Methodological manual [Internet]. Luxembourg: European Union; 2018 [cited 2024 Jul 23]. Available from: https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/KS-02-18-240?inheritRedirect=true.
  13. Milic N, Stanisavljevic D, Krstic M, editors. The 2019 Serbian National Health Survey [Internet]. Belgrade: OMNIA BGD; 2021 [cited 2024 Nov 3]. Available from: https://publikacije.stat.gov.rs/G2021/pdfE/G20216003.pdf.
  14. Petkeviciene J, Ivanauskiene R, Klumbiene J. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014. Public Health. 2018 Mar;156:79-86. Přejít k původnímu zdroji...
  15. Eurostat. Cancer screening statistics [Internet]. Eurostat [cited 2024 July 23]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Cancer_screening_statistics#Cervical_cancer_screening.
  16. Mallafré-Larrosa M, Ritchie D, Papi G, Mosquera I, Mensah K, Lukas E, et al.; CBIG-SCREEN Consortium. Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries. Eur J Public Health. 2023 Jun 1;33(3):502-8. Přejít k původnímu zdroji...
  17. Đorđević G, Radević S, Janićijević K, Kanjevac TV, Simić-Vukomanović I, Radovanović S. The prevalence and factors associated with cervical cancer screening among women in the general population - evidence from the National Health Survey. Serbian Arch Med. 2020;148(7-8):474-9. Přejít k původnímu zdroji...
  18. Liu Y, Guo J, Zhu G, Zhang B, Feng XL. Changes in rate and socioeconomic inequality of cervical cancer screening in northeastern China from 2013 to 2018. Front Med (Lausanne). 2022 Oct 5;9:913361. doi: 10.3389/fmed.2022.913361. Přejít k původnímu zdroji... Přejít na PubMed...
  19. Altová A, Kulhánová I, Brůha L, Lustigová M. Breast and cervical cancer screening attendance among Czech women. Cent Eur J Public Health. 2021 Jun;29(2):90-5. Přejít k původnímu zdroji...
  20. Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nygård M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. BMC Public Health. 2011 Apr 26;11:264. doi: 10.1186/1471-2458-11-264. Přejít k původnímu zdroji... Přejít na PubMed...
  21. Rančić NK, Golubović MB, Ilić MV, Ignjatović AS, Živadinović RM, Đenić SN, et al. Knowledge about cervical cancer and awareness of human papillomavirus (HPV) and HPV vaccine among female students from Serbia. Medicina (Kaunas). 2020 Aug 13;56(8):406. doi: 10.3390/medicina56080406. Přejít k původnímu zdroji... Přejít na PubMed...
  22. Broberg G, Wang J, Östberg AL, Adolfsson A, Nemes S, Sparén P, et al. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study. PloS One. 2018 Jan 10;13(1):e0190171. doi: 10.1371/journal.pone.0190171. Přejít k původnímu zdroji... Přejít na PubMed...
  23. Bozhar H, McKee M, Spadea T, Veerus P, Heinävaara S, Anttila A, et al; EU-TOPIA consortium. Socio-economic inequality of utilization of cancer testing in Europe: a cross-sectional study. Prev Med Rep. 2022 Feb 8;26:101733. doi: 10.1016/j.pmedr.2022.101733. Přejít k původnímu zdroji... Přejít na PubMed...
  24. Israel S. How social policies can improve financial accessibility of healthcare: a multi-level analysis of unmet medical need in European countries. Int J Equity Health. 2016 Mar 5;15:41. doi: 10.1186/s12939-016-0335-7. Přejít k původnímu zdroji... Přejít na PubMed...
  25. Health statistical yearbook of Republic of Serbia 2023. Belgrade: Institute of Public Health of Serbia "Dr Milan Jovanović Batut"; 2024.
  26. Lucas E, Murillo R, Arrossi S, Bárcena M, Chami Y, Nessa A, et al. Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand. Elife. 2023 May 16;12:e86527. doi: 10.7554/eLife.86527. Přejít k původnímu zdroji... Přejít na PubMed...
  27. Boričić K, Vasić M, Grozdanov J, Gudelj Rakić J, Živković Šulović M, Jaćović Knežević, N, et al. Results of the National Health Survey of the Republic of Serbia, 2013 [Internet]. Belgrade: The Institute of Public Health of Serbia "Dr Milan Jovanović Batut"; 2014 [cited 2024 Nov 15]. Available from: http://www.batut.org.rs/download/publikacije/2013SerbiaHealthSurvey.pdf.
  28. Ozturk NY, Hossain SZ, Mackey M, Adam S, Brennan P. HPV and cervical cancer awareness and screening practices among migrant women: a narrative review. Healthcare (Basel). 2024 Mar 23;12(7):709. doi: 10.3390/healthcare12070709. Přejít k původnímu zdroji... Přejít na PubMed...
  29. Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in Africa: a systematic review. BMC Public Health. 2024 Feb 20;24(1):525. doi: 10.1186/s12889-024-17842-1. Přejít k původnímu zdroji... Přejít na PubMed...
  30. Markovic M, Kesic V, Topic L, Matejic B. Barriers to cervical cancer screening: a qualitative study with women in Serbia. Soc Sci Med. 2005 Dec;61(12):2528-35. doi: 10.1016/j.socscimed.2005.05.001. Přejít k původnímu zdroji... Přejít na PubMed...